ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 284

What Is the Relative Priority of the ACR Pediatric Core Set Measures for Youth With Juvenile Idiopathic Arthritis and Their Parents?

Jaime Guzman1, Oralia Gomez-Ramirez2, Susanne M. Benseler3, Roberta A. Berard4, Rollin Brant5, Ciaran M. Duffy6, Roman Jurencak7, Kiem Oen8, Ross E. Petty9, Natalie J. Shiff10 and Lori B. Tucker11, 1Pediatric Rheum/Rm K4-122, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 2Anthropology, University of British Columbia, Vancouver, BC, Canada, 3Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Children's Hospital of Western Ontario, London, ON, Canada, 5Statistics, University of British Columbia, Vancouver, BC, Canada, 6Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 7University of Ottawa, Ottawa, ON, Canada, 8University of Manitoba, Winnipeg, MB, Canada, 9Pediatric Rheumatology, BC Children's Hosptial, Vancouver, BC, Canada, 10Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, 11Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), outcome measures and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects I: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: The ACR has endorsed a core set of six measures to assess the course of JIA and the impact of treatment: active joint count, limited joint count, physician’s global assessment of disease activity, functional ability, patient/parent’s global assessment of well being and a laboratory measure of inflammation. We sought to determine the relative priority given by patients and their parents to the ACR pediatric core measures, in relation to other disease features.

Methods: Three separate study sessions consisting of focus group discussions and reciprocal interviews (participants interview each other), were conducted with youth with JIA, experienced parents and novice parents.  Participant youth (7 female, 2 male, aged 16 to 23 years old) had JIA for 2 to 12 years (1 oligo, 2 poly, 2 systemic, 2 ERA, 1 psoriatic, 1 unclassified).  Experienced parents (5 female, 5 male, 2 couples) participated 9 months to 14 years after JIA diagnosis in their child (4 oligo, 1 poly, 1 ERA, 1 psoriatic, 1 unclassified).  Novice parents (5 female, 3 male, one couple) participated 2 to 6 months after JIA diagnosis in their child (2 oligo, 1 systemic, 1 ERA, 1 psoriatic, 2 unclassified). A list of 34 clinical features often used for the monitoring of JIA in cohort studies and therapeutic trials was provided to participants. The list included the core set ACR pediatric measures and lay language definitions for all the features.  Participants were asked to add any other relevant features, and discuss the features’ relative priority in describing the course of JIA.  Focus group discussions were professionally facilitated, recorded, and transcribed. Reciprocal interview answers were reported in standard forms.  Focus group transcripts and interview answers underwent content analysis by two investigators; themes and priority rankings were discussed with all co-authors.

Results: Among core set measures, the active joint count was considered to be of high priority by parents and of medium priority by youth.  The parent’s global assessment was considered to have medium priority by parents and low priority by youth.  The limited joint count and functional ability were considered to have low priority by the three groups. The physician global assessment was not discussed to any extent or given any priority, although the concept of disease activity was considered to be important.  Laboratory measures were not discussed.  By contrast, youth and parents gave high priority to pain, quality of life, medications required to control the disease and medication side-effects.  Youth felt that visual analogue scales and standardized questionnaires were poor reflections of their experiences with JIA.  Experienced parents were particularly interested in disease flares and flare triggers.  Novice parents were still coming to terms with the emotional impact of their child’s JIA diagnosis and found the prioritizing task difficult.

Conclusion: Among the six core measures, only the number of active joints has enough relevance in the eyes of youth and parents to be considered a central feature of JIA course.  If more patient-relevant measures are desired, consideration should be given to include pain and quality of life indicators as core set measures.


Disclosure:

J. Guzman,
None;

O. Gomez-Ramirez,
None;

S. M. Benseler,
None;

R. A. Berard,
None;

R. Brant,
None;

C. M. Duffy,
None;

R. Jurencak,
None;

K. Oen,
None;

R. E. Petty,
None;

N. J. Shiff,
None;

L. B. Tucker,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-is-the-relative-priority-of-the-acr-pediatric-core-set-measures-for-youth-with-juvenile-idiopathic-arthritis-and-their-parents/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology